QIAGEN powered by

Confident classifications for every variant, every disease, every patient

The content core of QCI Interpret One, the QIAGEN Clinical Knowledge Base transforms unstructured data into actionable insight, providing you with dynamically computed variant classifications for every alteration, in every disease, for every patient case.

Over 200,000 tumors interpreted

New to QIAGEN Clinical Insights is the inclusion of oncologist-reviewed interpretative comments from N-of-One. With over a decade of experience in clinical genomics interpretation for oncology, N-of-One’s team has interpreted more than 200,000 tumor samples for pathologists and lab directors. 

Variant scientists and oncologists translate molecular data specific to each patient into state-of-the-art clinical insights within minutes, giving you immediate access to variant-and disease-specific expert summaries. Aggregated knowledge from N-of-One experts and the QIAGEN Clinical Knowledge Base allows you to confidently classify variants and better determine their clinical significance.

Superior structured content

New to QIAGEN Clinical Insights is the inclusion of oncologist-reviewed interpretative comments from N-of-One. With over a decade of experience in clinical genomics interpretation for oncology, N-of-One’s team has interpreted more than 200,000 tumor samples for pathologists and lab directors. 

Variant scientists and oncologists translate molecular data specific to each patient into state-of-the-art clinical insights within minutes, giving you immediate access to variant-and disease-specific expert summaries. Aggregated knowledge from N-of-One experts and the QIAGEN Clinical Knowledge Base allows you to confidently classify variants and better determine their clinical significance.

Through QCI Interpret One, you access:
  • >170,000 oncologist-reviewed variant- and disease-specific interpretation summaries
  • > 170,000 variant-specific expert molecular impact summaries
  • FDA approved therapeutics
  • Worldwide open and recruiting clinical trials
  • Professional guidelines (NCCN, ACMG, AMP/ASCO/CAP, WHO)
  • Curated bibliography of >300,000 variant-specific articles with hyperlinked citations for quick confirmation
  • >25 databases, including COSMIC, ClinVar, and population frequency database, such gnomAD and QIAGEN’s Allele Frequency Community (AFC)
  • Weekly updated therapeutic, prognostic, and diagnostic evidence, including drug labels, recruiting clinical trials, practice guidelines, and clinical/functional studies